|
Volumn 27, Issue 7, 2016, Pages 1352-1353
|
Pembrolizumab-induced necrotic myositis in a patient with metastatic melanoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
CREATINE KINASE;
PEMBROLIZUMAB;
IMMUNOLOGICAL ANTINEOPLASTIC AGENT;
MONOCLONAL ANTIBODY;
AGED;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER RECURRENCE;
CANCER STAGING;
CASE REPORT;
DELIRIUM;
DIFFERENTIAL DIAGNOSIS;
DRUG SAFETY;
DRUG WITHDRAWAL;
DYSPHONIA;
ELECTROMYOGRAPHY;
ELECTRONEUROMYOGRAPHY;
FATIGUE;
FEMALE;
FOLLOW UP;
HUMAN;
LIMB WEAKNESS;
LUNG METASTASIS;
METASTATIC MELANOMA;
MUSCLE BIOPSY;
MYASTHENIA;
MYOSITIS;
NECROTIC MYOSITIS;
NEUROPATHY;
OPHTHALMOPLEGIA;
PARANOIA;
PLASMAPHERESIS;
PRIORITY JOURNAL;
PTOSIS;
TREATMENT RESPONSE;
VERY ELDERLY;
CHEMICALLY INDUCED;
DELTOID MUSCLE;
DRUG EFFECTS;
LUNG TUMOR;
MELANOMA;
NECROSIS;
PATHOLOGY;
SECONDARY;
AGED, 80 AND OVER;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC AGENTS, IMMUNOLOGICAL;
DELTOID MUSCLE;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
MELANOMA;
MYOSITIS;
NECROSIS;
|
EID: 84977090451
PISSN: 09237534
EISSN: 15698041
Source Type: Journal
DOI: 10.1093/annonc/mdw126 Document Type: Letter |
Times cited : (62)
|
References (5)
|